Andrew Kay

Chairman at NeRRe Therapeutics

Andrew has extensive board and business experience both in Biotech and major pharmaceutical companies. Currently Chairman Nucana Plc, Chairman Blueberry Therapeutics, Consultant & Advisor to Boards and Executive teams in Biotech and Healthcare companies. Director of Amulet Consulting specialising in advisory roles with biotech.

Links